NCT00561197 2013-01-04An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction CancerAscenta TherapeuticsPhase 1/2 Terminated13 enrolled